Lung Cancer Screening e-learning part

Will be open again from May 02 – October 31

General Information

ESTI offers the 6 LCS webinars + 3 case-based lectures (in total 9 lectures) on a dedicated platform where you can view them anytime between May 02 and October 31 (6 months). Registration deadline is Sunday, October 15, 2023. During this period, you will have the chance to do nine (9) self-assessment tests. Passmark for each self-assessment test is 90%. You will have the chance to do the test as often as you want (during the mentioned period), until you reach the passmark 90%.

Registration

Costs to enter the e-learning platform and to do the nine (9) self-assessment tests: 50,00 EUR
The login details to enter the e-learning platform will be sent once per month (beginning of each month). You will then have access until end of October 2023. Registration deadline: Sunday, October 15, 2023
A cancellation of the registration will not result in a refund.

Confirmation

You will automatically receive the confirmation of a self-assessment test, if you passed the same. If you successfully pass all nine (9) self-assessment tests by end of October 2023, an overall confirmation will be sent to you end of the year 2023.

Available lectures on the e-learning platform

LCS Webinar 4.01
An overview of LCS: A summary of the main trial results, from ELCAP to NELSON
Cornelia Schaefer-Prokop, Amersfoort/NL

LCS Webinar 4.02
Technical requirements for LCS: How to perform the acquisition (dose, slice thickness), How to read the scans
Annemiek Snoeckx, Edegem/BE

LCS Webinar 4.03
Solid nodule morphological evaluation: How to recognise obviously benign/malignant nodules, how to recognise intrapulmonary lymph nodes, pitfalls
Anand Devaraj, London/UK

LCS Webinar 4.04
Solid nodule measurement and follow‐up, criteria of positive screens
Helmut Prosch, Vienna/AT; Mario Silva, Parma/IT

LCS Webinar 4.05
Subsolid nodules: Evaluation and follow-up, criteria of positive screens
Marie-Pierre Revel, Paris/FR

LCS Webinar 4.06
Incidental findings in lung cancer screening: What to report?
Hans-Ulrich Kauczor, Heidelberg/DE

LCS case-based lecture 1
Solid nodule morphological evaluation: how to recognise obviously benign/malignant nodules, intrapulmonary lymph nodes, and pitfalls
Anand Devaraj, London/UK

LCS case-based lecture 2
Solid nodules case-based session: Benignity and malignancy criteria, pitfalls of interpretation
Mathieu Lederlin, Rennes/FR

LCS case-based lecture 3
Subsolid nodules evaluation, follow-up and criteria of positive screens
Marie-Pierre Revel, Paris/FR